Prototheca: A Danger Underwater.

Area of Science:

• Medical Mycology
• Infectious Diseases
• Immunocompromised Hosts

Background:

• Prototheca wickerhamii is a rare cause of human infection, typically seen in immunocompromised individuals.
• Systemic infections by Prototheca wickerhamii are infrequent and often associated with underlying health conditions.
• Opportunistic infections pose significant challenges in managing immunocompromised patients.

Purpose of the Study:

• To illustrate the clinical manifestation of Prototheca wickerhamii infection in an immunosuppressed patient.
• To document the treatment and outcome of a rare systemic algal infection.
• To contribute to the understanding of Prototheca wickerhamii pathogenesis in vulnerable populations.

Main Methods:

• Case report of a single immunosuppressed patient.
• Clinical presentation and diagnostic findings were documented.
• Treatment response to antifungal therapy was monitored.

Main Results:

• The patient presented with lesions indicative of Prototheca wickerhamii infection.
• Successful treatment was achieved using Liposomal amphotericin B.
• Complete resolution of the lesions was observed post-treatment.

Conclusions:

• Liposomal amphotericin B is an effective treatment for Prototheca wickerhamii infections.
• Immunosuppression is a key risk factor for developing Prototheca wickerhamii infections.
• Early diagnosis and appropriate antifungal therapy are crucial for favorable outcomes.